Literature DB >> 28930537

Differences in ion channel phenotype and function between humans and animal models.

Mark R Tanner1, Christine Beeton2.   

Abstract

Ion channels play crucial roles in regulating a broad range of physiological processes. They form a very large family of transmembrane proteins. Their diversity results from not only a large number of different genes encoding for ion channel subunits but also the ability of subunits to assemble into homo- or heteromultimers, the existence of splice variants, and the expression of different regulatory subunits. These characteristics and the existence of very selective modulators make ion channels very attractive targets for therapy in a wide variety of pathologies. Some ion channels are already being targeted in the clinic while many more are being evaluated as novel drug targets in both clinical and preclinical studies. Advancing ion channel modulators from the bench to the clinic requires their assessment for safety and efficacy in animal models. While extrapolating results from one species to another is tempting, doing such without careful evaluation of the ion channels in different species presents a risk as the translation is not always straightforward. Here, we discuss differences between species in terms of ion channels expressed in selected tissues, differing roles of ion channels in some cell types, variable response to pharmacological agents, and human channelopathies that cannot fully be replicated in animal models.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28930537      PMCID: PMC5626566          DOI: 10.2741/4581

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  127 in total

1.  Species comparison and pharmacological characterization of human, monkey, rat, and mouse TRPA1 channels.

Authors:  Bruce R Bianchi; Xu-Feng Zhang; Regina M Reilly; Philip R Kym; Betty B Yao; Jun Chen
Journal:  J Pharmacol Exp Ther       Date:  2012-02-07       Impact factor: 4.030

Review 2.  Cystic fibrosis genetics: from molecular understanding to clinical application.

Authors:  Garry R Cutting
Journal:  Nat Rev Genet       Date:  2014-11-18       Impact factor: 53.242

3.  Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretion.

Authors:  James Herrington; Yun-Ping Zhou; Randal M Bugianesi; Paula M Dulski; Yue Feng; Vivien A Warren; McHardy M Smith; Martin G Kohler; Victor M Garsky; Manuel Sanchez; Michael Wagner; Kristin Raphaelli; Priya Banerjee; Chinweze Ahaghotu; Denise Wunderler; Birgit T Priest; John T Mehl; Maria L Garcia; Owen B McManus; Gregory J Kaczorowski; Robert S Slaughter
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

4.  Voltage-dependent Na+ and Ca2+ currents in human pancreatic islet beta-cells: evidence for roles in the generation of action potentials and insulin secretion.

Authors:  D W Barnett; D M Pressel; S Misler
Journal:  Pflugers Arch       Date:  1995-12       Impact factor: 3.657

5.  Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.

Authors:  Christine Beeton; Heike Wulff; Nathan E Standifer; Philippe Azam; Katherine M Mullen; Michael W Pennington; Aaron Kolski-Andreaco; Eric Wei; Alexandra Grino; Debra R Counts; Ping H Wang; Christine J LeeHealey; Brian S Andrews; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Werner W Roeck; Jamshid Tehranzadeh; Kimber L Stanhope; Pavel Zimin; Peter J Havel; Stephen Griffey; Hans-Guenther Knaus; Gerald T Nepom; George A Gutman; Peter A Calabresi; K George Chandy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

6.  Electrophysiological characterization of pancreatic islet cells in the mouse insulin promoter-green fluorescent protein mouse.

Authors:  Yuk M Leung; Ishtiaq Ahmed; Laura Sheu; Robert G Tsushima; Nicholas E Diamant; Manami Hara; Herbert Y Gaisano
Journal:  Endocrinology       Date:  2005-08-18       Impact factor: 4.736

Review 7.  Chlorotoxin: Structure, activity, and potential uses in cancer therapy.

Authors:  Paola G Ojeda; Conan K Wang; David J Craik
Journal:  Biopolymers       Date:  2016-01       Impact factor: 2.505

8.  Expression of voltage-gated K+ channels in human atrium.

Authors:  Federica Bertaso; Claire C Sharpe; Bruce M Hendry; Andrew F James
Journal:  Basic Res Cardiol       Date:  2002-11       Impact factor: 17.165

9.  Analysis of transient receptor potential ankyrin 1 (TRPA1) in frogs and lizards illuminates both nociceptive heat and chemical sensitivities and coexpression with TRP vanilloid 1 (TRPV1) in ancestral vertebrates.

Authors:  Shigeru Saito; Kazumasa Nakatsuka; Kenji Takahashi; Naomi Fukuta; Toshiaki Imagawa; Toshio Ohta; Makoto Tominaga
Journal:  J Biol Chem       Date:  2012-07-12       Impact factor: 5.157

10.  Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats.

Authors:  Katherine L Tuggle; Susan E Birket; Xiaoxia Cui; Jeong Hong; Joe Warren; Lara Reid; Andre Chambers; Diana Ji; Kevin Gamber; Kengyeh K Chu; Guillermo Tearney; Li Ping Tang; James A Fortenberry; Ming Du; Joan M Cadillac; David M Bedwell; Steven M Rowe; Eric J Sorscher; Michelle V Fanucchi
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

View more
  17 in total

1.  KCa1.1 channels as therapeutic targets for rheumatoid arthritis.

Authors:  Christine Beeton
Journal:  Expert Opin Ther Targets       Date:  2017-10-31       Impact factor: 6.902

Review 2.  How Functional Genomics Can Keep Pace With VUS Identification.

Authors:  Corey L Anderson; Saba Munawar; Louise Reilly; Timothy J Kamp; Craig T January; Brian P Delisle; Lee L Eckhardt
Journal:  Front Cardiovasc Med       Date:  2022-07-04

3.  Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment.

Authors:  Arvin H Soepriatna; Tae Yun Kim; Mark C Daley; Elena Song; Bum-Rak Choi; Kareen L K Coulombe
Journal:  Cell Mol Bioeng       Date:  2021-09-29       Impact factor: 3.337

4.  Targeting KCa1.1 Channels with a Scorpion Venom Peptide for the Therapy of Rat Models of Rheumatoid Arthritis.

Authors:  Mark R Tanner; Michael W Pennington; Brayden H Chamberlain; Redwan Huq; Elizabeth J Gehrmann; Teresina Laragione; Pércio S Gulko; Christine Beeton
Journal:  J Pharmacol Exp Ther       Date:  2018-02-16       Impact factor: 4.030

5.  A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues.

Authors:  Celinda M Kofron; Tae Yun Kim; Bum-Rak Choi; Kareen L K Coulombe; Fabiola Munarin; Arvin H Soepriatna; Rajeev J Kant; Ulrike Mende
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

6.  KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis.

Authors:  Mark R Tanner; Michael W Pennington; Satendra S Chauhan; Teresina Laragione; Pércio S Gulko; Christine Beeton
Journal:  Arthritis Res Ther       Date:  2019-01-07       Impact factor: 5.156

Review 7.  KCNMA1-linked channelopathy.

Authors:  Cole S Bailey; Hans J Moldenhauer; Su Mi Park; Sotirios Keros; Andrea L Meredith
Journal:  J Gen Physiol       Date:  2019-08-19       Impact factor: 4.086

Review 8.  Drug Screening with Genetically Encoded Fluorescent Sensors: Today and Tomorrow.

Authors:  Ekaterina S Potekhina; Dina Y Bass; Ilya V Kelmanson; Elena S Fetisova; Alexander V Ivanenko; Vsevolod V Belousov; Dmitry S Bilan
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

9.  Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus.

Authors:  Marat Khodoun; Ameet A Chimote; Farhan Z Ilyas; Heather J Duncan; Halima Moncrieffe; K Shashi Kant; Laura Conforti
Journal:  Sci Adv       Date:  2020-11-18       Impact factor: 14.136

10.  An emerging spectrum of variants and clinical features in KCNMA1-linked channelopathy.

Authors:  Jacob P Miller; Hans J Moldenhauer; Sotirios Keros; Andrea L Meredith
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.